Livzon Pharma Proposes RMB10.20 per 10 Shares Special Interim Dividend; EGM Slated for 24 September 2026

Bulletin Express
09/08

Livzon Pharmaceutical Group Inc. (Livzon Pharma) has announced plans to distribute a special interim cash dividend of RMB10.20 (tax inclusive) for every 10 shares, equivalent to approximately RMB1.02 per share. The payout, subject to shareholder approval at the Extraordinary General Meeting (EGM) on 24 September 2026, will return an estimated RMB905.67 million to investors.

The dividend will be funded entirely from internal resources. Management stated that the group’s strong first-half 2026 performance, sizable retained earnings and robust cash position enable the payout without affecting liquidity, solvency or ongoing R&D and operational requirements.

Key distribution terms: • Share base: 887.91 million shares (588.10 million A shares; 299.81 million H shares). • Currency: A-share holders will receive RMB; H-share holders will be paid in Hong Kong dollars, converted at the RMB/HKD central parity rate on 24 September 2026. • Record dates: 13 October 2026 for A shares; 15 October 2026 for H shares. • Payment date: on or before 3 November 2026. • Shares held in the company’s repurchase account are excluded from the distribution. Livzon Pharma currently holds no treasury shares.

Tax withholding: • Mainland individual A-share investors: no immediate withholding. • QFII/RQFII holders of A shares: 10% corporate income tax. • Overseas individual H-share investors: 20% individual income tax. • Overseas non-resident enterprise H-share investors: 10% corporate income tax. • Southbound Trading Link investors: dividends paid in RMB; mainland individuals subject to 20% individual income tax, while mainland enterprises handle their own tax filings.

Governance timeline: • EGM: 2:00 p.m., 24 September 2026, Zhuhai headquarters. • Shareholders must register by 4:30 p.m., 18 September 2026 to vote. • Voting will be by poll; no shareholders are required to abstain.

The board unanimously recommends approval of the special interim dividend, citing alignment with the company’s commitment to sustained shareholder returns.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10